Summit Trail Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Summit Trail Advisors's JNJ Position: Q2 2026 in Review
Summit Trail Advisors reduced its Johnson & Johnson (JNJ) stake by 0.5% in Q2 2026, selling an estimated $120K and leaving 102,279 shares worth $26M. The position accounts for 0.33% of the portfolio, ranked #42.
Summit Trail Advisors first reported a position in JNJ in Q4 2017 and has held it in 26 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Summit Trail Advisors held 102,279 shares of Johnson & Johnson worth $26M as of Q2 2026.
- Summit Trail Advisors sold 513 Johnson & Johnson shares in Q2 2026, an estimated $120K.
- Johnson & Johnson made up 0.33% of Summit Trail Advisors's portfolio in Q2 2026, its #42 holding.
- Summit Trail Advisors first reported a position in Johnson & Johnson in Q4 2017 and has held it in 26 quarters since.
- 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.